Global Viral Vectors and Plasmid DNA Manufacturing Market Insights, Forecast to 2029

Global Viral Vectors and Plasmid DNA Manufacturing Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Plasmid DNA
1.2.3 Viral Vectors
1.3 Market by Application
1.3.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Cancers
1.3.3 Inherited Disorders
1.3.4 Viral Infections
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Perspective (2018-2029)
2.2 Global Viral Vectors and Plasmid DNA Manufacturing Growth Trends by Region
2.2.1 Viral Vectors and Plasmid DNA Manufacturing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Region (2018-2023)
2.2.3 Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Region (2024-2029)
2.3 Viral Vectors and Plasmid DNA Manufacturing Market Dynamics
2.3.1 Viral Vectors and Plasmid DNA Manufacturing Industry Trends
2.3.2 Viral Vectors and Plasmid DNA Manufacturing Market Drivers
2.3.3 Viral Vectors and Plasmid DNA Manufacturing Market Challenges
2.3.4 Viral Vectors and Plasmid DNA Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Viral Vectors and Plasmid DNA Manufacturing by Players
3.1.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Players (2018-2023)
3.1.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Players (2018-2023)
3.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Viral Vectors and Plasmid DNA Manufacturing, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Viral Vectors and Plasmid DNA Manufacturing Market Concentration Ratio
3.4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vectors and Plasmid DNA Manufacturing Revenue in 2022
3.5 Global Key Players of Viral Vectors and Plasmid DNA Manufacturing Head office and Area Served
3.6 Global Key Players of Viral Vectors and Plasmid DNA Manufacturing, Product and Application
3.7 Global Key Players of Viral Vectors and Plasmid DNA Manufacturing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vectors and Plasmid DNA Manufacturing Breakdown Data by Type
4.1 Global Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Type (2018-2023)
4.2 Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Type (2024-2029)
5 Viral Vectors and Plasmid DNA Manufacturing Breakdown Data by Application
5.1 Global Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Application (2018-2023)
5.2 Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size (2018-2029)
6.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
6.2.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2018-2023)
6.2.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2024-2029)
6.2.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2018-2029)
6.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
6.3.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2018-2023)
6.3.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2024-2029)
6.3.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2018-2029)
6.4 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country
6.4.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2018-2023)
6.4.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size (2018-2029)
7.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
7.2.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2018-2023)
7.2.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2024-2029)
7.2.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2018-2029)
7.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
7.3.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2018-2023)
7.3.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2024-2029)
7.3.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2018-2029)
7.4 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country
7.4.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2018-2023)
7.4.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Viral Vectors and Plasmid DNA Manufacturing Market Size (2018-2029)
8.2 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
8.2.1 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2018-2023)
8.2.2 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2024-2029)
8.2.3 China Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2018-2029)
8.3 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
8.3.1 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2018-2023)
8.3.2 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2024-2029)
8.3.3 China Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Viral Vectors and Plasmid DNA Manufacturing Market Size (2018-2029)
9.2 Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
9.2.1 Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2018-2023)
9.2.2 Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2024-2029)
9.2.3 Asia Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2018-2029)
9.3 Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
9.3.1 Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2018-2023)
9.3.2 Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2024-2029)
9.3.3 Asia Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2018-2029)
9.4 Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Region
9.4.1 Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2018-2023)
9.4.3 Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 BioReliance
11.1.1 BioReliance Company Details
11.1.2 BioReliance Business Overview
11.1.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Introduction
11.1.4 BioReliance Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
11.1.5 BioReliance Recent Developments
11.2 Cobra Biologics
11.2.1 Cobra Biologics Company Details
11.2.2 Cobra Biologics Business Overview
11.2.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Introduction
11.2.4 Cobra Biologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
11.2.5 Cobra Biologics Recent Developments
11.3 Oxford BioMedica
11.3.1 Oxford BioMedica Company Details
11.3.2 Oxford BioMedica Business Overview
11.3.3 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Introduction
11.3.4 Oxford BioMedica Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
11.3.5 Oxford BioMedica Recent Developments
11.4 UniQure
11.4.1 UniQure Company Details
11.4.2 UniQure Business Overview
11.4.3 UniQure Viral Vectors and Plasmid DNA Manufacturing Introduction
11.4.4 UniQure Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
11.4.5 UniQure Recent Developments
11.5 FinVector
11.5.1 FinVector Company Details
11.5.2 FinVector Business Overview
11.5.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Introduction
11.5.4 FinVector Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
11.5.5 FinVector Recent Developments
11.6 MolMed
11.6.1 MolMed Company Details
11.6.2 MolMed Business Overview
11.6.3 MolMed Viral Vectors and Plasmid DNA Manufacturing Introduction
11.6.4 MolMed Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
11.6.5 MolMed Recent Developments
11.7 MassBiologics
11.7.1 MassBiologics Company Details
11.7.2 MassBiologics Business Overview
11.7.3 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Introduction
11.7.4 MassBiologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
11.7.5 MassBiologics Recent Developments
11.8 Richter-Helm
11.8.1 Richter-Helm Company Details
11.8.2 Richter-Helm Business Overview
11.8.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Introduction
11.8.4 Richter-Helm Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
11.8.5 Richter-Helm Recent Developments
11.9 FUJIFILM Diosynth Biotechnologies
11.9.1 FUJIFILM Diosynth Biotechnologies Company Details
11.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Introduction
11.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
11.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments
11.10 Lonza
11.10.1 Lonza Company Details
11.10.2 Lonza Business Overview
11.10.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Introduction
11.10.4 Lonza Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
11.10.5 Lonza Recent Developments
11.11 Aldevron
11.11.1 Aldevron Company Details
11.11.2 Aldevron Business Overview
11.11.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Introduction
11.11.4 Aldevron Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
11.11.5 Aldevron Recent Developments
11.12 Eurogentec
11.12.1 Eurogentec Company Details
11.12.2 Eurogentec Business Overview
11.12.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Introduction
11.12.4 Eurogentec Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
11.12.5 Eurogentec Recent Developments
11.13 Cell and Gene Therapy Catapult
11.13.1 Cell and Gene Therapy Catapult Company Details
11.13.2 Cell and Gene Therapy Catapult Business Overview
11.13.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Introduction
11.13.4 Cell and Gene Therapy Catapult Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
11.13.5 Cell and Gene Therapy Catapult Recent Developments
11.14 Biovian
11.14.1 Biovian Company Details
11.14.2 Biovian Business Overview
11.14.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Introduction
11.14.4 Biovian Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
11.14.5 Biovian Recent Developments
11.15 Thermo Fisher Scientific (Brammer Bio)
11.15.1 Thermo Fisher Scientific (Brammer Bio) Company Details
11.15.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
11.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Introduction
11.15.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
11.15.5 Thermo Fisher Scientific (Brammer Bio) Recent Developments
11.16 VGXI
11.16.1 VGXI Company Details
11.16.2 VGXI Business Overview
11.16.3 VGXI Viral Vectors and Plasmid DNA Manufacturing Introduction
11.16.4 VGXI Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
11.16.5 VGXI Recent Developments
11.17 PlasmidFactory
11.17.1 PlasmidFactory Company Details
11.17.2 PlasmidFactory Business Overview
11.17.3 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Introduction
11.17.4 PlasmidFactory Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
11.17.5 PlasmidFactory Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Plasmid DNA
Table 3. Key Players of Viral Vectors
Table 4. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region (2018-2023)
Table 8. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region (2024-2029)
Table 10. Viral Vectors and Plasmid DNA Manufacturing Market Trends
Table 11. Viral Vectors and Plasmid DNA Manufacturing Market Drivers
Table 12. Viral Vectors and Plasmid DNA Manufacturing Market Challenges
Table 13. Viral Vectors and Plasmid DNA Manufacturing Market Restraints
Table 14. Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Players (2018-2023)
Table 16. Global Top Viral Vectors and Plasmid DNA Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors and Plasmid DNA Manufacturing as of 2022)
Table 17. Global Viral Vectors and Plasmid DNA Manufacturing Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Viral Vectors and Plasmid DNA Manufacturing Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Viral Vectors and Plasmid DNA Manufacturing, Headquarters and Area Served
Table 20. Global Key Players of Viral Vectors and Plasmid DNA Manufacturing, Product and Application
Table 21. Global Key Players of Viral Vectors and Plasmid DNA Manufacturing, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type (2018-2023)
Table 25. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type (2024-2029)
Table 27. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Application (2018-2023)
Table 29. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Application (2024-2029)
Table 31. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Viral Vectors and Plasmid DNA Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Viral Vectors and Plasmid DNA Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Viral Vectors and Plasmid DNA Manufacturing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Viral Vectors and Plasmid DNA Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2024-2029) & (US$ Million)
Table 63. BioReliance Company Details
Table 64. BioReliance Business Overview
Table 65. BioReliance Viral Vectors and Plasmid DNA Manufacturing Product
Table 66. BioReliance Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 67. BioReliance Recent Developments
Table 68. Cobra Biologics Company Details
Table 69. Cobra Biologics Business Overview
Table 70. Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Product
Table 71. Cobra Biologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 72. Cobra Biologics Recent Developments
Table 73. Oxford BioMedica Company Details
Table 74. Oxford BioMedica Business Overview
Table 75. Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Product
Table 76. Oxford BioMedica Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 77. Oxford BioMedica Recent Developments
Table 78. UniQure Company Details
Table 79. UniQure Business Overview
Table 80. UniQure Viral Vectors and Plasmid DNA Manufacturing Product
Table 81. UniQure Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 82. UniQure Recent Developments
Table 83. FinVector Company Details
Table 84. FinVector Business Overview
Table 85. FinVector Viral Vectors and Plasmid DNA Manufacturing Product
Table 86. FinVector Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 87. FinVector Recent Developments
Table 88. MolMed Company Details
Table 89. MolMed Business Overview
Table 90. MolMed Viral Vectors and Plasmid DNA Manufacturing Product
Table 91. MolMed Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 92. MolMed Recent Developments
Table 93. MassBiologics Company Details
Table 94. MassBiologics Business Overview
Table 95. MassBiologics Viral Vectors and Plasmid DNA Manufacturing Product
Table 96. MassBiologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 97. MassBiologics Recent Developments
Table 98. Richter-Helm Company Details
Table 99. Richter-Helm Business Overview
Table 100. Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Product
Table 101. Richter-Helm Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 102. Richter-Helm Recent Developments
Table 103. FUJIFILM Diosynth Biotechnologies Company Details
Table 104. FUJIFILM Diosynth Biotechnologies Business Overview
Table 105. FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Product
Table 106. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 107. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 108. Lonza Company Details
Table 109. Lonza Business Overview
Table 110. Lonza Viral Vectors and Plasmid DNA Manufacturing Product
Table 111. Lonza Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 112. Lonza Recent Developments
Table 113. Aldevron Company Details
Table 114. Aldevron Business Overview
Table 115. Aldevron Viral Vectors and Plasmid DNA Manufacturing Product
Table 116. Aldevron Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 117. Aldevron Recent Developments
Table 118. Eurogentec Company Details
Table 119. Eurogentec Business Overview
Table 120. Eurogentec Viral Vectors and Plasmid DNA Manufacturing Product
Table 121. Eurogentec Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 122. Eurogentec Recent Developments
Table 123. Cell and Gene Therapy Catapult Company Details
Table 124. Cell and Gene Therapy Catapult Business Overview
Table 125. Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Product
Table 126. Cell and Gene Therapy Catapult Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 127. Cell and Gene Therapy Catapult Recent Developments
Table 128. Biovian Company Details
Table 129. Biovian Business Overview
Table 130. Biovian Viral Vectors and Plasmid DNA Manufacturing Product
Table 131. Biovian Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 132. Biovian Recent Developments
Table 133. Thermo Fisher Scientific (Brammer Bio) Company Details
Table 134. Thermo Fisher Scientific (Brammer Bio) Business Overview
Table 135. Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Product
Table 136. Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 137. Thermo Fisher Scientific (Brammer Bio) Recent Developments
Table 138. VGXI Company Details
Table 139. VGXI Business Overview
Table 140. VGXI Viral Vectors and Plasmid DNA Manufacturing Product
Table 141. VGXI Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 142. VGXI Recent Developments
Table 143. PlasmidFactory Company Details
Table 144. PlasmidFactory Business Overview
Table 145. PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Product
Table 146. PlasmidFactory Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 147. PlasmidFactory Recent Developments
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Type: 2022 VS 2029
Figure 3. Plasmid DNA Features
Figure 4. Viral Vectors Features
Figure 5. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Application: 2022 VS 2029
Figure 7. Cancers Case Studies
Figure 8. Inherited Disorders Case Studies
Figure 9. Viral Infections Case Studies
Figure 10. Others Case Studies
Figure 11. Viral Vectors and Plasmid DNA Manufacturing Report Years Considered
Figure 12. Global Viral Vectors and Plasmid DNA Manufacturing Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Viral Vectors and Plasmid DNA Manufacturing Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region: 2022 VS 2029
Figure 15. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Players in 2022
Figure 16. Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors and Plasmid DNA Manufacturing as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Viral Vectors and Plasmid DNA Manufacturing Revenue in 2022
Figure 18. North America Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2018-2029)
Figure 20. North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2018-2029)
Figure 21. North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2018-2029)
Figure 22. United States Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2018-2029)
Figure 26. Europe Viral Vectors and Plasmid DNA Manufacturing Market

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs